Zhejiang Huahai Pharmaceutical Statistics

Total Valuation

Zhejiang Huahai Pharmaceutical has a market cap or net worth of CNY 25.37 billion. The enterprise value is 30.96 billion.

Market Cap	25.37B
Enterprise Value	30.96B

Important Dates

The last earnings date was Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	n/a

Share Statistics

Zhejiang Huahai Pharmaceutical has 1.45 billion shares outstanding. The number of shares has decreased by -0.16% in one year.

Current Share Class	n/a
Shares Outstanding	1.45B
Shares Change (YoY)	-0.16%
Shares Change (QoQ)	-1.04%
Owned by Insiders (%)	41.89%
Owned by Institutions (%)	18.97%
Float	840.01M

Valuation Ratios

The trailing PE ratio is 22.45 and the forward PE ratio is 15.50.

PE Ratio	22.45
Forward PE	15.50
PS Ratio	2.73
PB Ratio	2.97
P/TBV Ratio	n/a
P/FCF Ratio	21.67
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.83, with an EV/FCF ratio of 26.44.

EV / Earnings	27.15
EV / Sales	3.31
EV / EBITDA	11.83
EV / EBIT	17.41
EV / FCF	26.44

Financial Position

The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.78.

Current Ratio	1.40
Quick Ratio	0.76
Debt / Equity	0.78
Debt / EBITDA	2.65
Debt / FCF	5.93
Interest Coverage	8.14

Financial Efficiency

Return on equity (ROE) is 13.26% and return on invested capital (ROIC) is 7.14%.

Return on Equity (ROE)	13.26%
Return on Assets (ROA)	5.85%
Return on Capital (ROIC)	7.14%
Revenue Per Employee	1.14M
Profits Per Employee	138,691
Employee Count	8,221
Asset Turnover	0.49
Inventory Turnover	1.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.75% in the last 52 weeks. The beta is 0.13, so Zhejiang Huahai Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	+13.75%
50-Day Moving Average	17.91
200-Day Moving Average	16.33
Relative Strength Index (RSI)	42.57
Average Volume (20 Days)	16,467,621

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Zhejiang Huahai Pharmaceutical had revenue of CNY 9.35 billion and earned 1.14 billion in profits. Earnings per share was 0.78.

Revenue	9.35B
Gross Profit	5.81B
Operating Income	1.78B
Pretax Income	1.50B
Net Income	1.14B
EBITDA	2.60B
EBIT	1.78B
Earnings Per Share (EPS)	0.78

Full Income Statement

Balance Sheet

The company has 1.52 billion in cash and 6.94 billion in debt, giving a net cash position of -5.42 billion or -3.74 per share.

Cash & Cash Equivalents	1.52B
Total Debt	6.94B
Net Cash	-5.42B
Net Cash Per Share	-3.74
Equity (Book Value)	8.95B
Book Value Per Share	5.90
Working Capital	2.30B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.64 billion and capital expenditures -1.47 billion, giving a free cash flow of 1.17 billion.

Operating Cash Flow	2.64B
Capital Expenditures	-1.47B
Free Cash Flow	1.17B
FCF Per Share	0.81

Full Cash Flow Statement

Margins

Gross margin is 62.19%, with operating and profit margins of 19.02% and 12.20%.

Gross Margin	62.19%
Operating Margin	19.02%
Pretax Margin	16.08%
Profit Margin	12.20%
EBITDA Margin	27.80%
EBIT Margin	19.02%
FCF Margin	12.53%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.14%.

Dividend Per Share	0.20
Dividend Yield	1.14%
Dividend Growth (YoY)	-16.67%
Years of Dividend Growth	1
Payout Ratio	40.79%
Buyback Yield	0.16%
Shareholder Yield	1.30%
Earnings Yield	4.45%
FCF Yield	4.62%

Dividend Details

Stock Splits

The last stock split was on June 8, 2020. It was a forward split with a ratio of 1.1.

Last Split Date	Jun 8, 2020
Split Type	Forward
Split Ratio	1.1

Scores

Zhejiang Huahai Pharmaceutical has an Altman Z-Score of 2.66. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.66
Piotroski F-Score	n/a